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INTRODUCTION 
Plants are endowed with health promoting substances 
which are mainly the secondary metabolites like 
flavonoids. Most of the biologically active constituents of 
plants are polar or water soluble molecules. Toxicity and 
absorption problem limit the use of these constituents. 
Apart from that the herbal extracts are destroyed by the 
digestive secretions and gut bacteria. Extensive researches 
have been conducted for successful delivery of these plant 
derived products since the last century1. 
The term “phyto” means plant and “some” means cell 
like2. It is also mentioned as herbosomes. This is a new 
patented technology, where standardized plant extracts or 
water soluble phytoconstituents are complexed with 
phospholipids to produce lipid compatible molecular 
complexes, there by greatly increasing absorption and 
bioavailability3,4. Phosphatidylcholine, phosphatidylserine, 
phosphatidylethanolamine, phosphatidylinositol are the 
phospholipids used, but phosphatidylcholine are widely 
used because of their certain therapeutic value in case of 
liver diseases, alcoholic steatosis, drug induced liver 
damage and hepatitis. Phospholipids are also employed as 
natural digestive aids and as carriers for both fat miscible 
and water miscible nutrients5. Phytosomes can easily 
traverse the lipophilic path of the enterohepatic cell 
membranes6 and also stratum corneum layer of the skin3,7-
11. 
Standardized plant extracts mainly flavonoids are derived 
as phytosomes. Selection of flavonoids are done from the 
groups consisting of quercetin, kaemferol, quercretin-3, 
rhamnoglucoside, quercetin-3-rhamnoside, hyperoside, 
vitexine, diosmine, 3-rhamnoside, (+) catechin, (-) 
epicatechin, apigenin-7-glucoside, luteolin, 
luteolinglucoside, ginkgonetine, isoginkgonetine   and 
bilobetine etc. 
PHYTOSOME TECHNOLOGY & ITS ADVANTAGE 
The phytosome technology was developed by Indena s.p.A 
of Italy, markedly enhancing the bioavailability of selected 
phytomedicines, by incorporating phospholipids into 
standardized plant extract, which improve their absorption 
and utilization.  The polyphenols are little soluble both in 
water and in lipids. The polar functionalities of the 
lipophilic guest interact via hydrogen bonds and polar 
interaction with the charged phosphate head of 
phospholipids, forming a unique arrangement that can be 
evidenced by spectroscopy
8
. As phosphatidylcholine is a 
bifunctional molecule with hydrophilic choline and 
hydrophobic phosphatidyl group (Fig.1), the choline group 
head binds with the compound, while phosphatidyl portion 
envelopes the bounded part (Fig.2). 
The first phytosome generation was prepared by 
combining selected polyphenolic extract with 
phospholipids in non-polar solvent3, but recently the 
phytosome generations are developed by using hydro-
ethanolic solvent, to comply with current food 
specifications12. 
As compared to conventional herbal formulation, 
phytosome have following advantages13-16: 
 Greater therapeutic benefits, as absorption of lipid 
insoluble polar botanical extracts                 through 
oral and topical route is enhanced markedly. 
ABSTRACT 
The objective of this review is to focus on the application of phytosome technology along with its preparation, various properties 
and characterization. The recent development and conducted works of various researchers have been studied thoroughly to 
establish the transdermal route as a potential way to deliver phytoconstituents. Plant derived products or plant extracts are  
increasingly receiving attention as dietary supplements for the homeostatic management of inflammation, toxicities, cancers, 
weight loss and other chronic or acute degenerative disorders. But these products frequently face stability and bioavailabili ty 
problems. Plant products after their isolation become prone to instability and are potentially unfit to cross the biomembrane as 
such. Some plant products show hydrophobicity and their delivery to systemic circulation is a quite difficult task. The phytosome 
technique reduces these tasks to reasonable extents. Phytosomes or herbosomes are lipid compatible molecular complexes 
produced by interaction of standardized plant extracts and phospholipids with a stoichiometric ratio, having better stability,  
pharmacokinetics and pharmacodynamics profile. The phytosome or Herbosome technique increases the hydrophilicity of highly 
lipophilic drug there by making it suitable for drug delivery and increases the lipophilicity of hydrophilic phytoconstituents 
adequately to cross biological membrane. The topical application of phytosomes for cosmetic purpose has already been proven. 
This review contains a comparative account of liposomes and phytosomes along with recent advancements in the field of 
phytosome technology with a special concern to transdermal drug delivery. 
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 Small dose is required, as absorption is increased 
manifolds. 
 Phytosomes possess better drug entrapment efficiency. 
 Phosphatidylcholine is not merely a carrier; it is also 
having hepatoprotective activity and nutritional value. 
 Due to formation of chemical bonds, phytosomes 
show better stability profile. 
 Phytosomes can be used for systemic targeting of 
herbal drugs, as phytosome can easily transit from 
hydrophilic environment into the lipid friendly 
environment of the enterocyte cell membrane and 
from there to into the cell. 
 Cosmetic and other topical use of phytoconstituents 
can be done by phytosome formulations. 
 
PREPARATION METHOD OF PHYTOSOMES 
Phytosomes are prepared by reacting a synthetic or natural 
phospholipid with the standardized plant extract in a ratio 
ranging from 0.5-2.0. But usually 1:1 ratio is preferable. 
The reaction is carried out alone or in the natural mixture 
in aprotic solvent, such as, dioxane, methylene chloride, 
acetone; from which the novel complex can be isolated by 
precipitation with a non-solvent, usually an aliphatic 
hydrocarbon or by lyophilisation or by spay drying. The 
solubilization or complex formation is sometimes carried 
out by refluxing the stoichiometric ratio mixture for a 
specified period in the aprotic solvent.  
 
Figure1: Structure of Phosphatidylcholine 
 
Figure 2: Molecular arrangement showing hydrophobic tail 
surrounding the hydrophilic choline part 
The solvents may be evaporated by using rotary 
evaporators. Hence, after drying, the resulting complexes 
are soluble in polar and aprotic solvents, in which the 
individual components of the complex are usually 
insoluble. For the preparation of phytosome the 
phospholipids are choosen from the group consisting of 
soylecithin, from bovine or swine brain or dermis, 
phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylserine, in which acyl group  may be same or 
different and mostly derived from palmitic, stearic, oleic 
and linoleic acid17-21. 
PROPERTIES OF PHYTOSOMES 
1 Physico-chemical properties 
 As previously discussed, phytosomes are 
prepared by reaction of stoichiometric amount of 
phospholipid with the standardized plant extract as 
substrate. The spectroscopic data reveals that the 
phopspholipid- substrate interaction is due to the formation 
of hydrogen bond between the polar head (i.e., phosphate 
and ammonium group) and the polar functionalities of the 
substrate22. 
 The size of phytosome varies from 50 nm to a 
few hundred µm. 
 Phytosomes when treated with water, they assume 
a micellar shape resembling liposome and Photon 
Correlation Spectroscopy (PCS) reveals these liposomal 
structures acquired by Phytosomes.  
 From the 1HNMR and 13CNMR data, it can be 
deduced that the fatty chain gives unchanged signals both 
in free phospholipid and in the complex, which indicates 
that long aliphatic chains are wrapped around the active 
principle, producing lipophilic envelope. 
 Regarding the solubility of phytosomes, the 
complexes are often freely soluble in aprotic solvents, 
moderately soluble in fats, insoluble in water and relatively 
unstable in alcohol. But the phytosomes of certain 
lipophilic phytoconstituents like curcumin has shown 
increased water solubility upon complexation with 
phospholipids which has been discussed later in this paper. 
2 Biological properties 
Phytosomes   are novel complexes which are better 
absorbed and utilized, hence they produce more 
bioavailability and better result than the conventional 
herbal extract or non-complexed extracts, which has been 
demonstrated by pharmacokinetic studies or by 
pharmacodynamic tests in experimental animals and in 
human subjects23. 
Phytosomes express their behaviour in physical or 
biological system because of their physical size, membrane 
permeability, percentage entrapment, chemical 
composition, quantity and purity of the materials used. The 
phytosomes should not be confused with liposomes where 
hydrophilic drug molecules are entrapped within a cavity 
or spaces between the membranes. The liposomes may 
involve several hundred phospholipid molecules for this 
entrapment and are usually now being used for cosmetic 
purposes. Instead, the phytosomes involves interaction of 
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1- 4 phospholipid molecules with the phytoconstituents 
which are chemically anchored to each other. Several 
researches have shown the phytosomes to be a better 
alternative for liposomes in terms of membrane 
permeability and stability. Fig.3 illustrates a comparative 
account of phytosomes with liposomes. 
 
Figure 3: Structural comparision of liposome with 
phytosome 
CHARACTERIZATION OF PHYTOSOMES 
The physical attributes like shape, size, distribution, drug 
entrapment capacity, drug release and chemical 
composition are used for their characterization. Methods 
used for their characterization are Melting point 
determination, Thin Layer Chromatography (TLC), Infra 
Red Spectroscopy, NMR spectroscopy, Differential 
Scanning Calorimetry, X-Ray Diffraction Analysis, 
Scanning Electron Microscopy (SEM), Transmission 
Electron Microscopy (TEM), Photon correlation 
Spectroscpy (PCS), Percentage drug entrapment etc24. 
The melting point of the prepared phytosomes significantly 
vary from that of the phytoconstituents and the 
phospholipid, which is due to the chemical interaction 
between the both moiety and the change in shape of the 
phytosome. The HP-TLC is a simple method used for 
characterization of Phytosome. The phytosomes have a 
retention factor value different from the phytoconstituents 
and phospholipids when they are eluted with the suitable 
solvent system18, which confirms the formation of a new 
molecular entity. 
The instrumental techniques used for the evaluation 
provide major informations. The FT-IR spectra of the 
phytoconstituent, the phospholipid and their phytosomes 
are compared. The free hydroxyl group interact with the 
choline part of phospholipid. The peak corresponding to 
the free hydroxyl group changes and a broad peak appears 
instead. The chemical shift value, presence and absence of 
NMR peak of particular proton can be investigated to 
characterize phytosome. The H-NMR Spectra of 
phytosomes of various phytoconstituents show the peak of 
long tail part of phospholipid molecule intact, which 
reveals that the tail part does not take part in any chemical 
interactions and behaves as a sheath to the central choline 
part attached to phytoconstituent25. The 13C-NMR is often 
performed for confirmation of the type of interaction 
involved for the complexation. 
The crystallinity of the phytoconstituents is lost upon 
complexation, which is responsible for increasing the 
hydrophilicity of hydrophobic phytoconstituent and 
balancing the hydrophilicity and lipophilicity. The 
crystallinity along with the interaction of phospholipid 
with phytoconstituent can be confirmed by the DSC and 
X-RD Analysis. The crystalline drug moiety shows a sharp 
peak at high melting point in DSC thermogram. The 
phytosome show a broad peak and a melting point 
significantly less than that of pure drug. The broad peak 
indicates the loss of crystallinity. Similarly the diffraction 
angle (2θ) of phospholipid, phytoconstituent and the 
phytosomes are compared. The general XRD study 
indicates loss of crystalline peaks of drugs which confirms 
the interaction and entrapment of drug within a sheath26. 
The study of surface morphology is often important in 
identifying the entrapment behaviour, surface properties 
along with the presence or absence of impurities on the 
surface. The SEM provides photomicrograph of the 
phytosomes at suitable magnification after coating it with a 
very thin layer of gold. The surface of phytosomes 
generally shows no crystalline particles or any impurity on 
surface. The spherical bulging on the surface are generally 
obtained, which confirms the spherical shape of the 
phytosomes (Fig.4). The internal environment where the 
drug is entrapped and its distribution within the 
phospholipid mesh may be clearly investigated from the 
TEM study27,24 (Fig.5).   
 The Photon Correlation Spectroscopy (PCS) 
technique is used for investigating the size of the 
phytosome and for confirmation of the vesicular structure 
after hydration and determination of size of vesicle. The 
polydispersity of vesicles are observed by this technique 
which gives an idea about distribution of various sizes of 
vesicular structures. The PCS study generally shows that 
the phytosomes upon hydration mostly forms unilamellar 
liposomal structures. 
The percentage drug entrapment can be determined by 
extracting the phytosomes with suitable solvent systems by 
centrifugation at higher rpm value for short time or a lower 
rpm value for longer period and estimating of the 
supernatant for detection of drug either by UV-Visible 
spectroscopy or High Performance Liquid 
Chrromatography (HPLC) method. 
 
Figure 4: SEM photomicrograph of Phytosomes27 
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.  
Figure 5: TEM photograph of phytosomes24 
ADVANCEMENT & RECENT RESEARCHES ON 
PHYTOSOMES  
Numerous research is being conducted by the researchers 
and the recent researches reveals that the phytosome 
technology is a novel method for improving the absorption 
and bioavailability of plant extracts significantly reducing 
the dose level. Some plant extracts are getting more focus 
now-a-days due to their potential pharmacological effects, 
such as, silymarin, grape seed extract, quercetin, curcumin, 
hesperetin, ginkgo biloba extract, andrographolide etc28,29. 
The suitability of this technique and increased demand of 
herbal medicines for various disease management in 
current scenario, has paved the way of newer researches. 
Some of the crucial works of various researchers are 
briefly given below. 
Schandalik et al, 1992, 1994, used nine human volunteer 
patients and tested the hepatoprotective activity of 
silymarin and reported that phytosomal form of silybin 
possess four times greater passage through the liver30,31. 
Similar experiment was conducted by Mascarella et al, 
1993, using 232 patients with chronic hepatitis. He also 
reported better bioavailability of silymarin phytosome than 
the uncomplexed form20. 
Grange et al, 1999, conducted series of experiments on 
silymarin phytosomes and reported the better 
fetoprotectant activity of the phytosomal form32. Busby et 
al, 2002, also reported better fetoprotectant activity of 
silymarin phytosome than uncomplexed silymarin against 
ethanol-induced behavioural deficit33.  
Jhiang et al, 2001, prepared Herba Epimedii flavonoid 
phytosome (EPF) by means of solvent evaporation 
technique and the accumulative dissolution of different 
ratios of EPF-PVP precipitate was investigated by 
dissolution study. The study showed that the dissolution of 
the precipitate was significantly higher than that of its 
physical mixture and Herba Epimedii extract tablets34. 
Bombardelli et al, 2005, reported that the silymarin 
phytosomes showed much higher specific activity and a 
longer lasting action than the single constituent, with 
respect to percent reduction of edema, inhibition of 
myeloperoxidase activity, antioxidant and free radical 
scavenging activity35. 
Maiti et al, 2005, developed a quercetin phytosome by a 
simple and reproducible method and reported that the 
phytosomal complex shows better therapeutic efficacy 
than the uncomplexed molecule in rat liver injury induced 
by carbon tetrachloride36. They also recently reported the 
enhanced bioavailability and hepatoprotective activity of 
andographolide herbosome by an experiment on rats and 
found that the phytosomal form has an enhanced activity 
than that of uncomplexed andrographolide at the same 
dose leevel37. Maiti et al, 2006, 2007, also developed 
naringenin and curcumin phytosomes in two different 
studies and reported that antioxidant activity of the 
phytosomal complex has better therapeutic efficacy19, 18. 
They developed simple methods of  preparation of 
phytosomes.  
Xiao et al, 2006, Prepared silymarin phytosomes and 
studied its pharmacokinetics in rats and reported that the 
bioavailability of silybin has increased markedly in 
phytosomal formulation21. Hepatoprotective activity of 
silymarin phytosomes was found to be more than silymarin 
alone against aflatoxin B1, as reported by Tedesco et al, 
2008, after performing the experiment on broiler chicks38. 
Green tea extract generally contains a totally standardized 
polyphenolic fraction (epigallocatechin and its 
derivatives), having a long term beneficial activities, such 
as, antioxidant, anticarcinogenic, antimutagenic, 
antiatherosclerotic, hypocholesterolemic, cardioprotective 
and antibacterial effects, but having a poor oral 
bioavailability. But the phytosomal formulation strongly 
improves the oral bioavailability. Further advancement in 
phytosome technology has been discussed in the following 
section. 
FEASIBILITY OF PHYTOSOME FOR 
TRANSDERMAL APPLICATION 
The enhanced bioavailability of phytoconstituents by 
transdermal route is a major breakthrough in the research 
of transdermal drug delivery systems (TDDS). TDDS 
involves the delivery of therapeutic agent via skin in to the 
systemic circulation. The stratum corneum, which is the 
outermost horny layer, provides the major hindrance for 
drug delivery due to its lipophilicity. The phytosomal form 
of the phytoconstituent is helpful in avoiding this barrier 
property. The successful research experience of around 
two decades of study by different researchers has been 
summarized below, which indicates that the phytosome 
technology has enough potency to be used transdermally 
for increasing bioavailability of phytoconstituents. 
Bombardelli   et al, (1991) observed that phospholipid 
exhibit a  marked affinity  for some classes of flavonoids. 
They developed a new series of compounds called 
Phytosomes, which he obtained by complexation of 
phospholipid with very polar botanical derivatives, i.e. 
complexes between a pure phospholipid and pure active 
principle.  He  first  established  some  chemicophysical 
properties of phytosomes of catechin, quercetin,  escin  and 
glycyrrhetinic  acid  and  gathered  some pharmacological  
data.  He, from the beginning described phytosomes to be 
a good carrier for phytoconstituents across the skin8. 
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Loggia  et al,  (1996)  prepared  Gingko biloba terpenes 
phytosomes and reported that the phytosome  was  
effective  on  soothing  individual  contact reaction  to 
other substances  contained in topical formulation9. 
Yanyu  et al, (2006)  investigated  that  the well  known  
soothing  activity of silymarin  is  increased by more than 
six times in sylimarin phytosome in experimental models.  
The improvement in the activity  of the phytosome form 
compared to the free active  principle  is  due  to  a higher  
affinity  of  the complex  for skin  phospholipid21. 
Kidd (2009) reported the hydration of the superficial 
corneous layer is related to the liposomal like properties of 
the phospholipid of the complex. Ginselect phytosomes 
posses a transdermic action which helps the  ginseng 
saponin present in the phospholipid complex to penetrate 
into the skin39. 
Forster et al, (2009) and Chanchal and Swarnlata (2008) 
reported in there review that the topical delivery of plant 
derived products can be effectively done in cosmetic 
preparation by phospholipid complexation10,11. 
Cao et al, (2010) formulated Oxymatrine-phospholipid 
complex (OMT-PLC) to improve the lipid solubility and 
effectiveness of OMT. The purpose of their study was to 
explore the utility of the combination of a microemulsion 
and an OMT-PLC as topical delivery vehicle for 
enhancing the absorption and efficacy of OMT. The 
solubility of OMT-PLC was determined and phase 
diagram of microemulsion were constructed. They 
developed various physicochemical properties and In Vitro 
and In Vitro permeability through skin. They concluded 
that the combination of a microemulsion and phospholipid 
complex represents an effective vehicle for topical delivery 
of OMT40. 
Gupta and Dixit, (2011) reported that incorporation of 
high amount of curcumin in topical formulation cannot 
provide a better bioavailability. They prepared complex of 
curcumin with phosphatidylcholine  and characterized  
them  on  the  basis  of  TLC,  DSC,  Melting point  and  
FT-IR. They compared the activity of vesicular systems 
like liposome, niosome, phytovesicle.  In result they got 
that the phytovesicles are having  excellent  antioxidant  
and  antiaging  properties  than  the other vesicular 
systems,  that may be due to the amphiphilic  nature of the 
complex,  which  greatly enhances  the  water  and  lipid  
miscibility  of  the  curcumin24. 
Cuomo et al, (2011)  investigated  the  relative  absorption 
of a standardized curcuminoids mixture  and its  
corresponding  lecithin formulation (Meriva) in  a  
randomized,  double  blind  cross over  design  human 
study.  They reported the improved absorption and a better 
plasma curcuminoid profile of the Meriva at a dose 
significantly lower than unformulated curcuminoid 
mixture41. 
Zaveri et al, (2011) have prepared the curcumin-
phospholipid complex in a molar ratio of (1:2) of curcumin 
and phospholipid. They confirmed the formation of 
complex by FT-IR Spectroscopy and DSC analysis. They 
compared the skin permeation of curcumin with the 
complexed curcumin and found that the complexed 
curcumin showed 60% greater permeation of curcumin 
through rat skin. They reported that the phospholipid 
complex has more transdermal penetration than pure 
curcumin42. 
CONCLUSION  
Phytosomes or herbosomes are advanced and novel form 
of botanicals and    phytoconstituents that are better 
absorbed both orally, topically and transdermally. 
Phytosomes have improved pharmacokinetics and 
pharmacological parameters and having wide scope in 
cosmeticology. The preparation methods of phytosomes 
are non-conventional, simple and reproducible. Apart from 
that the phospholipids used have their own beneficial 
effect to the body. Many areas of phytosomes are to be 
reported in the future in the prospect of pharmaceutical 
application. The phytosome technology forms a link 
between the conventional delivery system of 
phytoconstituents and novel drug delivery systems.
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